2 registrations that name vinpocetine as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 2 registrations
Status
Phase
All 2 registrations
RecruitingNCT07229664
Vinpocetine in Patients With Parkinsonian Disease
Phase 2 and 3
Tanta University
About 60 people
Started Nov 10, 2025
In plain words A Phase 2 and 3 study of vinpocetine in people 50 to 70, run by Tanta University. It plans to enroll about 60 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 50 to 70. Conditions: Parkinson Disease.
What it tests, as registered
Levodopa Carbidopa; Vinpocetine
Registered summary
The clinical manifestations of Parkinson's disease (PD), a chronic neurodegenerative condition, include resting tremor, hypokinesia, bradykinesia, stiffness and postural instability. These motor symptoms are caused by a selective loss and degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) region, which leads to a dopamine (DA) insufficiency in the striatum
Where, as registered
No US site; Egypt (1).
Not yet recruitingNCT06635746
Dose Escalation Study of Vinpocetine in Healthy Volunteers
Phase 1
Stanford University
About 20 people
Starts Jun 1, 2025 (estimated)
In plain words A Phase 1 study of vinpocetine in people 18 to 40, run by Stanford University. It plans to enroll about 20 people and lists no sites yet.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 40; healthy volunteers accepted. Conditions: Fetal Alcohol Spectrum Disorders.
Healthy adults 18-40 years old.
Proficient English.
Use of appropriate contraception if woman of childbearing potential.
The exclusion criteria are on the listing.
What it tests, as registered
Vinpocetine
Registered summary
The objective of this study is to determine whether vinpocetine is safe when taken at higher doses.